Bg pattern

FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Fampridine Aurovitas 10 mg prolonged-release tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Fampridine Aurovitas and what is it used for
  2. What you need to know before you take Fampridine Aurovitas
  3. How to take Fampridine Aurovitas
  4. Possible side effects
  5. Storage of Fampridine Aurovitas
  6. Contents of the pack and other information

1. What is Fampridine Aurovitas and what is it used for

Fampridine Aurovitas contains the active substance fampridine, which belongs to a group of medicines called potassium channel blockers. They work by slowing down the release of potassium from damaged nerve cells in Multiple Sclerosis (MS). It is thought that this medicine works by allowing signals to pass through the nerve in a more normal way, which helps you to walk better.

Fampridine is a medicine used to improve walking in adults (18 years or older) with MS who have walking disability. In multiple sclerosis, inflammation damages the protective covering of the nerves, leading to muscle weakness, muscle stiffness, and difficulty walking.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Fampridine Aurovitas

Do not takeFampridineAurovitas

  • if you are allergic to fampridine or any of the other ingredients of this medicine (listed in section 6).
  • if you have had seizures (fits or convulsions) or if your doctor or nurse has told you that you have a history of seizures.
  • if your doctor or nurse has told you that you have moderate or severe kidney problems.
  • if you are taking a medicine called cimetidine.
  • if you are taking another medicine that contains fampridine. This could increase the risk of you having serious side effects.

Tell your doctor and do not takethis medicine if any of these apply to you.

Warnings and precautions

Talk to your doctor or pharmacist before you start taking this medicine.

  • if you are aware of your heartbeat (palpitations).
  • if you are prone to infections.
  • if you have any risk factors or are taking any medicines that affect the risk of having seizures (fits or convulsions).
  • if your doctor has told you that you have mild kidney problems.
  • if you have a history of allergic reactions.

You should use a walking aid, such as a walking stick, as needed, because this medicine may make you feel dizzy or unsteady and may increase the risk of falls.

Tell your doctor beforeyou take this medicine if any of these apply to you.

Children and adolescents

Do not give this medicine to children or adolescents under 18 years.

Elderly

Before starting treatment and during treatment, your doctor may check that your kidneys are working properly.

Other medicines andFampridineAurovitas

Tell your doctor or pharmacistif you are taking, have recently taken or might take any other medicines.

Do not take this medicine if you are taking other medicines that contain fampridine.

Other medicines that affect the kidneys

Your doctor will be careful if you are given fampridine at the same time as another medicine that may affect how other medicines are removed from the body by the kidneys, such as carvedilol, propranolol, and metformin.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Fampridine should not be used during pregnancy.

Your doctor will weigh up the benefit of treatment with fampridine for you against the risk for the baby.

Breast-feeding should be stopped during treatment with this medicine.

Driving and using machines

Fampridine may affect your ability to drive or use machines, it can cause dizziness. Make sure it does not affect you before you start driving or using machines.

3. How to take Fampridine Aurovitas

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. This medicine can only be obtained with a prescription and under the supervision of doctors with experience in MS.

Your doctor will initially prescribe treatment for 2 to 4 weeks. After this period of 2 to 4 weeks, the treatment will be re-evaluated.

The recommended dose is

Onetablet in the morning and onetablet in the evening (12 hours apart). Do not take more than two tablets in one day. There must be 12 hoursbetween each tablet. Do not take the tablets more often than every 12 hours.

Fampridine is taken by mouth.

Swallow the tablet whole, with water. Do not divide, crush, dissolve, suck, or chew the tablet. This could increase the risk of you having side effects.

This medicine should be taken on an empty stomach, without food.

If you take moreFampridineAurovitas than you should

Contact your doctor immediatelyif you take too many tablets.

If you go to a doctor, take the pack of this medicine with you.

If you have a overdose you may notice sweating, small tremors (tremors), dizziness, confusion, memory loss (amnesia), and seizures (fits or convulsions). You may also notice other effects not mentioned here.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.

If you forget to takeFampridineAurovitas

If you forget to take a tablet, do not take a double dose to make up for forgotten doses. There must always be 12 hoursbetween each tablet.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you have a seizure, stop taking fampridineand tell your doctor immediately.

If you experience one or more of the following allergic reactions (hypersensitivity): swelling of the face, mouth, lips, throat, or tongue, redness or itching of the skin, chest tightness, and breathing problems, stop taking fampridine and see a doctor immediately.

The following side effects are listed by frequency:

Very common side effects(may affect more than 1 in 10 people):

  • Urinary tract infection.

Common side effects(may affect up to 1 in 10 people):

  • Lack of balance.
  • Dizziness.
  • Feeling that everything is spinning (vertigo).
  • Headache.
  • Feeling weak and tired.
  • Difficulty sleeping.
  • Anxiety.
  • Small tremors (tremors).
  • Numbness or tingling in the skin.
  • Sore throat.
  • Common cold (nasopharyngitis).
  • Flu.
  • Viral infection.
  • Breathing difficulties (shortness of breath).
  • Feeling sick (nausea).
  • Being sick (vomiting).
  • Constipation.
  • Stomach upset.
  • Back pain.
  • Feeling your heartbeat (palpitations).

Uncommon side effects(may affect up to 1 in 100 people):

  • Seizures (fits or convulsions).
  • Allergic reaction (hypersensitivity).
  • Severe allergic reaction (anaphylactic reaction).
  • Swelling of the face, lips, mouth, or tongue (angioedema).
  • Appearance or worsening of facial nerve pain (trigeminal neuralgia).
  • Fast heart rate (tachycardia).
  • Dizziness or fainting (hypotension).
  • Redness of the skin with itching (urticaria).
  • Chest discomfort.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Agency's website for reporting adverse reactions (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Fampridine Aurovitas

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date is the last day of the month shown.

Store below 30°C.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and other information

What Fampridine Aurovitas contains

  • The active substance is fampridine. Each prolonged-release tablet contains 10 mg of fampridine.
  • The other ingredients are:

Core of the tablet:microcrystalline cellulose (grade 102), hypromellose type 2208 (100 mPa.s, grade for controlled release),colloidal anhydrous silica, and magnesium stearate.

Coating of the tablet:hypromellose 2910 (5 mPa.s),macrogol 400, talc, titanium dioxide (E171).

Appearance and packaging

Prolonged-release tablet.

White or almost white, oval (13.1 x 8.1 mm approximately), biconvex, film-coated tablets with "FN" on one side and "10" on the other.

Fampridine Aurovitas prolonged-release tablets are available in blister packs.

Blister pack sizes:

14, 16, 24, 28, 30, 56, 60, 98, 100, 196, and 200 prolonged-release tablets.

Not all pack sizes may be marketed.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Aurovitas Spain, S.A.U.

Avda. de Burgos, 16-D

28036 Madrid

Spain

Phone: 91 630 86 45

Manufacturer

APL Swift Services (Malta) Limited

HF26, Hal Far Industrial Estate, Hal Far

Birzebbugia, BBG 3000

Malta

Or

Generis Farmacêutica, S.A.

Rua João de Deus, 19

2700-487 Amadora

Portugal

Or

Arrow Génériques

26 Avenue Tony Garnier

69007 Lyon

France

This medicine is authorised in the Member States of the European Economic Area under the following names:

Germany: Fampridin PUREN 10 mg Retardtabletten

Spain: Fampridina Aurovitas 10 mg comprimidos de liberación prolongada EFG

France: Fampridine Arrow LP 10 mg, comprimé à libération prolongée

Netherlands: Fampridine Aurobindo 10 mg, tabletten met verlengde afgifte

Portugal: Fampridina Generis

Date of last revision of this leaflet: May 2022

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

Online doctors for FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS

Discuss questions about FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS?
FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS?
The active ingredient in FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS is fampridine. This information helps identify medicines with the same composition but different brand names.
Who manufactures FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS?
FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS is manufactured by Aurovitas Spain, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to FAMPRIDINE AUROVITAS 10 mg PROLONGED-RELEASE TABLETS?
Other medicines with the same active substance (fampridine) include FAMPRIDINE ACCORD 10 mg PROLONGED-RELEASE TABLETS, FAMPRIDINE QUALIGEN 10 mg PROLONGED-RELEASE TABLETS, FAMPRIDINE SANDOZ 10 mg PROLONGED-RELEASE TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media